To view abstracts from prior years, click one of the years to the left to open the search function.

For reference in writing a successful abstract, please refer to the following:

Featured Basic/Translational Abstracts, 2019 

• • pdf B3 - Differential Gene Expression in Metastatic Pancreatic Neuroendocrine Tumors Predicts Novel Therapeutic Agents (71 KB)
  • pdf B10 - Development of Anti-SSTR CAR T Cells for Future Treatment of NETS (79 KB)
  • pdf B6 - CDK-Targeted Combination Therapies of Pancreatic Neuroendocrine Tumors (PNETS) Guided by RABL6A-Dependent Regulation of the PNET Kinome and Phosphoproteome (67 KB)
  • pdf B16 - Imipridone ONC201 Blocks Tumor Growth by Inhibiting RET/IGFBP2 Pathway in Medullary Thyroid Cancer (64 KB)

Featured Clinical Abstracts, 2019 

• • pdf C6 - Randomized Phase II Trial of Pazopanib Versus Placebo in Patients (Pts) With Progressive Carcinoid Tumors (CARC) (Alliance A021202) (68 KB)
  • pdf C43 - Clinical Implications of Pathogenic Germline Variants in Small Intestine Neuroendocrine Tumors (70 KB)
  • pdf C38 - SKIE: An Automated Approach to Quantitation of KI-67 Indexfrom Human Gastrointestinal Neuroendocrine Tumor (79 KB)
  • pdf C20 - 64Cu-DOTATATE Somatostatin Receptor Imaging in Neuroendocrine Tumor Patients: Experience From More Than 600 Patients (65 KB)  

2020 Submission Period is Closed 

Submitted abstracts are currently being reviewed and scored. Accepted abstracts will be posted on or before September 4, 2020. 

The Abstract Process

NANETS is committed to furthering neuroendocrine tumor disease diagnosis, treatment and management through research and education. With over 15,000 new patients diagnosed with NETs each year, there is a continuing need to support NET research and advance the dissemination of vital research findings. NANETS' Multidisciplinary NET Medical Virtual Symposium represents an excellent opportunity to present research relevant to cutting edge topics in neuroendocrine tumor research. Medical researchers at institutions in North America and around the world are invited to submit abstracts for presentation. NANETS encourages abstract reporting on recent NET research and/or describing ongoing or current clinical trials with the intent of increasing awareness of these studies.

Investigators may submit abstracts that have been presented at other scientific meetings and/or published in scientific journals since October 1 of the prior year. Abstracts are reviewed and scored by NANETS’ Scientific Review & Research Committee of NET medical research experts, and selected to be shown in poster sessions or as oral abstract presentations at the NANETS Annual Multidisciplinary NET Medical Symposium, held each fall. Ten to twelve oral abstracts will be selected for presentation in two education sessions at Symposium.  

Categories for submission are:

1. 1. Basic Science
   2. Applied Basic Science
   3. Chemo/SSA/Biologics (Clinical)
   4. Nuclear Medicine/Interventional Radiology/Imaging (Clinical)
   5. Surgical/Applied Pathology (Clinical)
   6. Population Science
   7.  Other
   8. Trials in Progress

Case reports are not accepted.

Abstracts are published in a comprehensive guide featuring the latest in NET research, archived on NANETS' website, as well as a large number being published in the medical journal Pancreas.